Clinical Trial Update: To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin [Phase 1]

View source ↗

Summary

This is a completed Phase 1 clinical trial evaluating the safety and tolerability of multiple oral doses of AZD1656 added to metformin in adults with Type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED